Kiran Samindla, MD
Nephrology · Frederick, MDNPI 1932300845
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $491,250 of the $491,487 with a category attached, or 100.0%. 9 manufacturers reported payments, led by CSL Behring at 50.1% of the total. Among nephrology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 303 payments — averaging $1622.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$246K
- CSL Plasma Inc.$245K
- Mallinckrodt Enterprises LLC$100
- Calliditas Therapeutics US Inc.$37
- AstraZeneca$23
- ANI Pharmaceuticals, Inc.$20
- plus $56 from 3 others
What the payments were for
- Consulting fees$491,250100%
- Food & beverage$1370%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 148 | $246,000 |
| CSL Plasma Inc. | 147 | $245,250 |
| Mallinckrodt Enterprises LLC | 1 | $100 |
| Calliditas Therapeutics US Inc. | 2 | $37 |
| AstraZeneca | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Akebia Therapeutics Inc | 1 | $18 |
How this compares
$491,487 in reported general payments places this provider in the 95th percentile of 285 nephrology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 12 | $567 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Frederick
- Rohan RengenFrederick$32K
- Anita NaharFrederick$7K
- Branislav RomanicFrederick$4K
- Matthew WeirBaltimore$490K
- Chirag ParikhBaltimore$186K
- Mohamad HanounehBaltimore$174K
- Daniel BrennanBaltimore$133K
- Monika DhillonBaltimore$126K
- Duvuru GeethaBaltimore$91K
- Eli RozaHagerstown$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.